DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool

Friday, October 5, 2018 Genetics & Stem Cells News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Oct. 4, 2018 /PRNewswire/ -- DNA Damage Response (DDR) is essential for maintaining the genomic integrity of the

cell, and its disruption is one of the hallmarks of cancer. Targeting DDR deficiencies to preferentially kill cancer cells, while minimizing the impact on normal cells, has potential for more selective, better tolerated therapies to improve survival
in multiple cancers.Download the full report: https://www.reportbuyer.com/product/5576158 DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool is the most up to date and comprehensive commercial pipeline review and competitive assessment available on this hot and fast moving area in oncology. This unique product is truly the only one of its kind and is designed to give you a competitive edge in your DDR drug intelligence.Your DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool is based on two decades of proven methodology in serving clients with interest in:* Target Scouting* Early & Late Stage Pipeline Analysis* Biomarker/Companion Diagnostic Analysis* Deal & Alliance Analysis* Combination Therapy Analysis* Clinical Trial Results Analysis* Indication Selection & Expansion Analysis* First-in-Class Analysis* Drug Repositioning* Pipeline Analysis by Targeted PathwaysAnalytical Tools transform your computer's desktop into a high capacity workbench within your area of choice. Even before launching this tool you have already eliminated hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf.Your DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool covers more than 390 companies plus partners who are today developing 820 DDR drugs where of 491 are in active developmental in cancer across 220 different targets. Any data and/or analysis from the Analytical Tool is yours to keep and data/graphs/tables can be easily exported into Excel/PDF and various graphic formats for mixing with your own proprietary information.Let our expertise work for youWhile executing some of your daily tasks in our Analytical Tools, you will benefit from almost two decades of our experience in perfecting features and analysis, allowing you to easily create breakdowns, tables, graphs and exports for your reports, presentations and conference attendance via our easy to use point and click interface.Support and inspiration at your finger-tipsYou also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.A tool to grow with and keep you informedUnlike a static report which just represents a particular snapshot in time, all of the Analytical Tools come with one year of free online access to twice-weekly updates in both contents and features, pipeline alerts and online support. You can choose to renew your access to these updates and support on a yearly basis or go over to our industry leading full service platform covering all oncology drug development, 1stOncology.Your key to accessing the 1stOncology NewsDeskAs a special bonus, your Analytical Tool unlocks lifetime(*) access to the 1stOncology Newsdesk! This service, which is normally reserved for full 1stOncology users only, is a live stream of breaking news within the oncology industry. Updated every 5 minutes, you can tune in to specific channels such as Social Media, Clinical Trials, Intellectual Property, Financial data and Press Releases. This is a great tool to ensure your surveillance of your area of interest is complete.Format & Free UpdatesThis is 12 months of access to an ever-green Analytical Tool that you access simply online. It is continuously updated with new information and analysis throughout your 12 month access period, ensuring that you stay up to date with this fast moving field. At the end of your access period, if you so wish, you can choose to renew.System Requirements- Browser Application (Supports: Internet Explorer, FireFox, Chrome and Safari))- Internet access(*) In this context, lifetime access refers to the full period of time that BioSeeker Group offers a Newsdesk product or similar news based service.Download the full report: https://www.reportbuyer.com/product/5576158 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/dna-damage-response-ddr-drugs-in-oncology-analytical-tool-300724699.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store